Literature DB >> 16548002

Papillary carcinoma of the breast in a male patient with a treated prostatic carcinoma diagnosed by fine-needle aspiration biopsy: a case report and review of the literature.

Walid E Khalbuss1, Abiy Ambaye, Steve Goodison, Asif Loya, Shahla Masood.   

Abstract

Papillary carcinoma of the male breast is very rare. In this case report, we describe the cytologic, histologic, immunohistochemical, and radiological findings of a papillary carcinoma of male breast. A 67-yr-old man, who had a previous history of prostatic adenocarcinoma, presented with a retroareolar painless mass. There was no known history of breast cancer in his family. A fine-needle aspiration biopsy (FNAB) was performed. Cytological examination revealed a cellular aspirate with three-dimensional papillary clusters. A diagnosis of papillary lesion favoring papillary carcinoma was rendered. Immunohistochemical staining of the cell-block of the FNAB revealed the presence of mammaglobin, and the absence of prostatic specific antigen. The patient underwent lumpectomy, which showed a moderately differentiated infiltrating papillary carcinoma with adjacent areas of ductal carcinoma in situ. FNAB is a useful technique in identifying male breast carcinoma. In conjunction with ancillary studies, this procedure can effectively differentiate between a primary versus metastatic lesion. 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16548002      PMCID: PMC3428056          DOI: 10.1002/dc.20402

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  18 in total

1.  The differential diagnosis of papillary tumors of the breast.

Authors:  F T KRAUS; R D NEUBECKER
Journal:  Cancer       Date:  1962 May-Jun       Impact factor: 6.860

2.  Papillary carcinoma of the male breast diagnosed by fine needle aspiration cytology.

Authors:  N Joshi; C Pande
Journal:  Indian J Pathol Microbiol       Date:  1998-01       Impact factor: 0.740

3.  Male breast cancer: a retrospective study with immunohistochemical analysis of hormone receptor expression.

Authors:  P H Tan; I T Sng
Journal:  Pathology       Date:  1997-02       Impact factor: 5.306

4.  Male breast cancer in Iceland.

Authors:  J G Jonasson; B A Agnarsson; S Thorlacius; J E Eyfjord; H Tulinius
Journal:  Int J Cancer       Date:  1996-02-08       Impact factor: 7.396

5.  BRCA2 mutation in Icelandic prostate cancer patients.

Authors:  S Sigurdsson; S Thorlacius; J Tomasson; L Tryggvadottir; K Benediktsdottir; J E Eyfjörd; E Jonsson
Journal:  J Mol Med (Berl)       Date:  1997-10       Impact factor: 4.599

6.  Papillary carcinoma of the breast. Cytologic study of nine cases.

Authors:  P V Kumar; A R Talei; S A Malekhusseini; A Monabati; M Vasei
Journal:  Acta Cytol       Date:  1999 Sep-Oct       Impact factor: 2.319

7.  Carcinoma of the breast in males: a multiinstitutional survey.

Authors:  W L Donegan; P N Redlich; P J Lang; M T Gall
Journal:  Cancer       Date:  1998-08-01       Impact factor: 6.860

8.  Male patients with diagnoses of both breast cancer and prostate cancer.

Authors:  Stacey B Leibowitz; Judy E Garber; Edward A Fox; Massimo Loda; Donald S Kaufman; Philip W Kantoff; William K Oh
Journal:  Breast J       Date:  2003 May-Jun       Impact factor: 2.431

9.  Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?

Authors:  Shahla Masood; Asif Loya; Walid Khalbuss
Journal:  Diagn Cytopathol       Date:  2003-06       Impact factor: 1.582

10.  Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer.

Authors:  X Gao; A Zacharek; A Salkowski; D J Grignon; W Sakr; A T Porter; K V Honn
Journal:  Cancer Res       Date:  1995-03-01       Impact factor: 12.701

View more
  1 in total

1.  Invasive Papillary Carcinoma of the Male Breast Misdiagnosed as Fibroadenoma on FNAB.

Authors:  Richa Katiyar; Shashikant C U Patne; Sandip Kumar; Rahul Khanna
Journal:  J Clin Diagn Res       Date:  2017-02-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.